Cargando…

A Case Series of Acquired Factor Inhibitor Following Sars-COV2-Vaccination

Abstract : Autoimmune disorders post viral illness and post vaccination are some of the known complications. COVID 19 is known to cause complement dysregulation and possible reactivation of known autoimmune disorders. New data are emerging on the possible autoimmune reactivation and cases of de novo...

Descripción completa

Detalles Bibliográficos
Autor principal:	Jayananda, Sriraksha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology. Published by Elsevier Inc. 2021
Materias:	322.Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701480/ http://dx.doi.org/10.1182/blood-2021-153754

Ejemplares similares

Study of Coagulopathies in Covid 19 Positive Patients & Their Correlation with Outcome of Disease
por: Khunger, Jitender, et al.
Publicado: (2020)

VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study
por: Madeeva, Daria V, et al.
Publicado: (2020)

COVID-19 in Relation to Hematological Events (Thrombosis/Bleeding) and Mortality in Inpatient Setting
por: Gadde, Saikrishna, et al.
Publicado: (2020)

Plasma Exchange for COVID-19 Thrombo-Inflammatory Disease
por: Thomas, Mari, et al.
Publicado: (2020)

Venous Thromboembolic Disease in Children Associated with COVID-19
por: Narang, Shalu, et al.
Publicado: (2020)

Coagulation Dysfunction and Hematological Changes in 633 Patients with COVID-19
por: Yang, Mo, et al.
Publicado: (2020)

Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study
por: Crowther, Mark, et al.
Publicado: (2020)

In Covid-19 Infection, Plasma Extracellular Vesicle Tissue Factor Activity Does Not Correlate with D-Dimer Levels
por: Girard, Thomas J., et al.
Publicado: (2021)

Rapid Disappearance of Lupus Anticoagulant in Novel Coronavirus 2019 Patients; Is It the Key to Pandora's Box?
por: Kim, Hyunji, et al.
Publicado: (2021)

Hemophilia in Patients 50 Years or Older: Quality of Life, Health Maintenance, Cancer Screening and COVID19
por: Katiyar, Vatsala, et al.
Publicado: (2021)

Are Cardiovascular Risk Factors also Associated with the Incidence of Atrial Fibrillation?: A Systematic Review and Field Synopsis of 23 Factors in 32 Population-Based Cohorts of 20 Million Participants
por: Allan, Victoria, et al.
Publicado: (2017)

Long-Acting Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Children: Results of a Phase 3 Trial
por: Kenet, Gili, et al.
Publicado: (2016)

THE EFFECT OF THE COVID-19 PANDEMIC PROCESS ON TREATMENT COMPLIANCE IN HEMOPHILIA PATIENTS
por: Şahin, Şifa, et al.
Publicado: (2022)

Polyphosphate Delays Fibrin Polymerisation and Alters the Mechanical Properties of the Fibrin Network
por: Whyte, Claire S., et al.
Publicado: (2016)

Impact of Fibrinogen Carbamylation on Fibrin Clot Formation and Stability
por: Binder, Veronika, et al.
Publicado: (2017)

Pharmacokinetics of Recombinant Human Soluble Thrombomodulin in Disseminated Intravascular Coagulation Patients with Acute Renal Dysfunction
por: Hayakawa, Mineji, et al.
Publicado: (2017)

Platelet Turnover Predicts Outcome after Coronary Intervention
por: Freynhofer, Matthias K., et al.
Publicado: (2017)

Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic
por: Patel, Rachna, et al.
Publicado: (2021)

Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis
por: Mutch, N J, et al.
Publicado: (2010)

Leukemia‐associated Rho guanine‐nucleotide exchange factor is not critical for RhoA regulation, yet is important for platelet activation and thrombosis in mice
por: Williams, C. M., et al.
Publicado: (2015)

Profil épidémiologique de la COVID-19 du 15 mars 2020 au 15 mars 2022 à l’Établissement hospitalier universitaire régional de la Sûreté Nationale d'Oran
por: Boukhari, H., et al.
Publicado: (2022)

Fibrinolysis in a lipid environment: modulation through release of free fatty acids
por: RÁBAI, G, et al.
Publicado: (2007)

Hindered dissolution of fibrin formed under mechanical stress
por: Varjú, I, et al.
Publicado: (2011)

Lytic and mechanical stability of clots composed of fibrin and blood vessel wall components
por: Rottenberger, Z, et al.
Publicado: (2013)

Increased urokinase and consumption of α(2)‐antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay
por: Longstaff, C., et al.
Publicado: (2018)

On the localization of the cleavage site in human alpha‐2‐antiplasmin, involved in the generation of the non‐plasminogen binding form
por: Abdul, Shiraazkhan, et al.
Publicado: (2020)

VhH anti‐thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow
por: van Moorsel, Marc V. A., et al.
Publicado: (2022)

Assessment of the protein interaction between coagulation factor XII and corn trypsin inhibitor by molecular docking and biochemical validation
por: Hamad, B. K., et al.
Publicado: (2017)

A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X
por: TAI, S J, et al.
Publicado: (2008)

Factor XII truncation accelerates activation in solution
por: de Maat, S., et al.
Publicado: (2018)

Androgen receptor dampens tissue factor expression via nuclear factor‐κB and early growth response protein 1
por: Hoesel, B., et al.
Publicado: (2018)

Coagulation factor XII protease domain crystal structure
por: Pathak, M, et al.
Publicado: (2015)

Genomeâwide analysis of genetic determinants of circulating factorÂVIIâactivating protease (FSAP) activity
por: Olsson, M., et al.
Publicado: (2018)

Sirtilins – the new old members of the vitamin K‐dependent coagulation factor family
por: Dahms, Sven O., et al.
Publicado: (2019)

Biochemical and functional characterization of a recombinant monomeric factor VIII–Fc fusion protein
por: PETERS, R T, et al.
Publicado: (2013)

The role of β‐barrels 1 and 2 in the enzymatic activity of factor XIII A‐subunit
por: Hethershaw, E. L., et al.
Publicado: (2018)

Redox control of β(2)-glycoprotein I–von Willebrand factor interaction by thioredoxin-1
por: PASSAM, F H, et al.
Publicado: (2010)

Four‐factor prothrombin complex concentrate reverses apixaban‐associated bleeding in a rabbit model of acute hemorrhage
por: Herzog, E., et al.
Publicado: (2015)

Identification of aggregates in therapeutic formulations of recombinant full‐length factor VIII products by sedimentation velocity analytical ultracentrifugation
por: Healey, J. F., et al.
Publicado: (2018)

Crosslinked clots formed independently of factor XIII and without fibrinogen‐to‐fibrin conversion – is this a liver‐specific phenomenon?
por: Lisman, T.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j9oa74agh3g90m53dsbavekv97